checkAd

    ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL  1276  0 Kommentare KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN)

    NEW ORLEANS, LA--(Marketwired - December 23, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead plaintiff applications in a securities class action lawsuit against Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), if they purchased the Company's securities between February 10, 2014 and November 9, 2016, inclusive (the "Class Period"). The action is pending in United States District Court, Southern District of New York.

    What You May Do

    If you purchased securities of Alexion and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 17, 2017.

    About the Lawsuit

    Alexion and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

    The alleged false and misleading statements and omissions include, but are not limited to, that: (i) Alexion employed improper sales practices with respect to its product Soliris; (ii) that the Company's revenues from Soliris sales were unlikely to be sustainable; and (iii) as a result of the foregoing, Alexion's public statements were materially false and misleading at all relevant times.

    Additionally, on December 12, 2016, Alexion announced the unscheduled departure of CEO David Hallal and CFO Vikas Sinha, who both resigned effective immediately.

    On this news, the price of Alexion's shares again plummeted.

    About Kahn Swick & Foti, LLC

    KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

    To learn more about KSF, you may visit www.ksfcounsel.com.

    Contact:
    Kahn Swick & Foti, LLC
    Lewis Kahn, Managing Partner
    lewis.kahn@ksfcounsel.com
    1-877-515-1850
    206 Covington St.
    Madisonville, LA 70447



    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Marketwired
    ALEXION SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Alexion Pharmaceuticals, Inc. - (ALXN) NEW ORLEANS, LA--(Marketwired - December 23, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until January 17, 2017 to file lead plaintiff …

    Schreibe Deinen Kommentar

    Disclaimer